Related references
Note: Only part of the references are listed.LL-37 Peptide Enhancement of Signal Transduction by Toll-like Receptor 3 Is Regulated by pH IDENTIFICATION OF A PEPTIDE ANTAGONIST OF LL-37
Divyendu Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 213/3 trial
Angel Chamorro et al.
LANCET NEUROLOGY (2014)
OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice
Munehisa Shimamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Intravenous Minocycline in Acute Stroke A Randomized, Controlled Pilot Study and Meta-analysis
Edith Kohler et al.
STROKE (2013)
Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury
Minoru Kawakami
BRAIN SCIENCES (2013)
Ischemic Stroke in Rats Enhances Bone Resorption in Vitro
Myung Eun Chung et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
TLR2-dependent Modulation of Osteoclastogenesis by Porphyromonas gingivalis through Differential Induction of NFATc1 and NF-κB
Ping Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Neuroplastin-65 and a mimetic peptide derived from its homophilic binding site modulate neuritogenesis and neuronal plasticity
Sylwia Owczarek et al.
JOURNAL OF NEUROCHEMISTRY (2011)
The immunology of stroke: from mechanisms to translation
Costantino Iadecola et al.
NATURE MEDICINE (2011)
Do RANKL inhibitors (denosumab) affect inflammation and immunity?
S. Ferrari-Lacraz et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Edaravone for acute ischaemic stroke
Shejun Feng et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Weihong Tu et al.
CELL (2010)
THYMOSIN β4 IMPROVES FUNCTIONAL NEUROLOGICAL OUTCOME IN A RAT MODEL OF EMBOLIC STROKE
D. C. Morris et al.
NEUROSCIENCE (2010)
Evaluation of Pharmaceuticals With a Novel 50-Hour Animal Model of Bone Loss
Yoshiya Tomimori et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic
Takato Abe et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Mutations within the TNF-Like Core Domain of RANKL Impair Osteoclast Differentiation and Activation
Taksum Cheng et al.
MOLECULAR ENDOCRINOLOGY (2009)
Central control of fever and female body temperature by RANKL/RANK
Reiko Hanada et al.
NATURE (2009)
Risk of Hip/Femur Fracture After Stroke A Population-Based Case-Control Study
Sander Pouwels et al.
STROKE (2009)
Angiotensin II accelerates osteoporosis by activating osteoclasts
Hideo Shimizu et al.
FASEB JOURNAL (2008)
Receptor activator of NF-κB ligand and osteoprotegerin regulate proinflammatory cytokine production in mice
Kenta Maruyama et al.
JOURNAL OF IMMUNOLOGY (2006)
Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain
N Zhang et al.
STROKE (2005)
Synthetic fibronectin peptide exerts neuroprotective effects on transient focal brain ischemia in rats
LR Zhao et al.
BRAIN RESEARCH (2005)
Post-training administration of a synthetic peptide ligand of the neural cell adhesion molecule, C3d, attenuates long-term expression of contextual fear conditioning
K Cambon et al.
NEUROSCIENCE (2003)
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
KD Burris et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke
Y Sato et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Share Paper
